TaiGen Biotechnology Announces Presentation of Nemonoxacin at the Joint Meeting of ICAAC/IDSA

TAIPEI, Taiwan--(BUSINESS WIRE)--Taipei, Taiwan –October 20 2008 – TaiGen Biotechnology Co., Ltd. today announced a total of 11 posters on its investigational drug nemonoxacin will be presented at the joint 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / 46th Annual Meeting of Infectious Diseases Society of America (IDSA) to be held in Washington, D.C. from October 25 – 28, 2008.

Back to news